PULM · Pulmatrix, Inc. · Executive Compensation
$1.60
+0.03 (+1.91%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, management believes that without the closing of the Merger, given our current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about our ability to continue as a going concern after the date that is one year from the date that these financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.88M
Shares
3.65M
Volume · Oct 5
24.31K
Avg daily vol (3M)
25.94K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Teofilo Raad | (former Chief Executive Officer) | $691,888 |
| Peter Ludlum | (Interim Chief Financial Officer) | $510,224 |
| Margaret Wasilewski | (former Chief Medical Officer) | $509,606 |
| Michelle S. Siegert | (former Vice President, Finance) | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Teofilo Raad | (Chief Executive Officer) | $1,007,072 |
| Margaret Wasilewski | (Chief Medical Officer) | $614,055 |
| Michelle S. Siegert | (Vice President, Finance) | $491,886 |
| Peter Ludlum | (Interim Chief Financial Officer) | $398,583 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Teofilo Raad | (Chief Executive Officer) | $1,381,954 |
| Michelle S. Siegert | (Vice President, Finance) | $480,275 |
| Margaret Wasilewski | (Chief Medical Officer) | — |
| Peter Ludlum | (Interim Chief Financial Officer) | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Teofilo Raad | (Chief Executive Officer) | $2,173,772 |
| Michelle S. Siegert | (Vice President, Finance) | $646,097 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Teofilo Raad | (Chief Executive Officer; Former Chief Business Officer) | $823,367 |
| Robert W. Clarke | (Former Chief Executive Officer) | $520,377 |
| William Duke | (Former Chief Financial Officer) | $465,271 |
| Michelle S. Siegert | (Vice President, Finance) | $320,352 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Robert W. Clarke | (Former Chief Executive Officer) | $1,250,624 |
| William Duke | (Former Chief Financial Officer) | $734,577 |
| Teofilo Raad | (Chief Executive Officer; Former Chief Business Officer) | $707,457 |
| Michelle S. Siegert | (Vice President, Finance) | $330,404 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Peter Ludlum | Interim Chief Executive Officer | Appointed | 2024-07-19 |
| Teofilo Raad | member of the Board | Resigned | 2024-07-19 |
| Teofilo Raad | Chief Executive Officer | Resigned | 2024-07-19 |
| Dr. Margaret Wasilewski | Chief Medical Officer | Terminated | 2024-03-13 |